Zimmer Biomet Holdings, Inc. Peer Comparison

Metric Value Ranking
Market Cap $22.8 Billion 6/16 ABT
$174.1B		 SYK
$124.7B		 BSX
$109.2B		 MDT
$100.6B		 EW
$36.0B		 ZBH
$22.8B		 BRKR
$9.7B		 BIO
$9.0B		 GKOS
$5.9B		 ITGR
$3.9B		 CNMD
$2.2B		 NUVA
$2.1B		 OFIX
$619.6M		 SRDX
$591.2M		 LUNG
$300.8M		 CVRX
$207.5M
Gross Margin 62% 10/16 CVRX
84%		 GKOS
76%		 EW
76%		 SRDX
75%		 LUNG
75%		 NUVA
72%		 BSX
69%		 MDT
66%		 OFIX
65%		 ZBH
62%		 SYK
61%		 ABT
56%		 CNMD
55%		 BIO
53%		 BRKR
49%		 ITGR
24%
Profit Margin 9% 6/16 BIO
63%		 EW
22%		 SYK
15%		 BSX
13%		 ABT
12%		 ZBH
9%		 MDT
8%		 BRKR
7%		 CNMD
6%		 ITGR
5%		 NUVA
2%		 SRDX
1%		 OFIX
-19%		 GKOS
-48%		 LUNG
-73%		 CVRX
-100%
EBITDA margin 30% 2/16 EW
33%		 ZBH
30%		 MDT
29%		 BSX
26%		 SYK
24%		 NUVA
19%		 ITGR
18%		 BRKR
16%		 BIO
16%		 ABT
15%		 CNMD
11%		 SRDX
9%		 OFIX
-7%		 GKOS
-20%		 LUNG
-75%		 CVRX
-205%
Quarterly Revenue $1.9 Billion 5/16 ABT
$10.0B		 MDT
$8.6B		 SYK
$5.2B		 BSX
$3.9B		 ZBH
$1.9B		 EW
$1.6B		 BRKR
$721.7M		 BIO
$610.8M		 ITGR
$414.8M		 NUVA
$317.8M		 CNMD
$312.3M		 OFIX
$188.6M		 GKOS
$85.6M		 SRDX
$32.0M		 LUNG
$18.9M		 CVRX
$10.8M
Quarterly Earnings $172.4 Million 7/16 ABT
$1.2B 		SYK
$788.0M 		MDT
$654.0M 		BSX
$492.0M 		BIO
$383.9M 		EW
$351.9M 		ZBH
$172.4M 		BRKR
$50.9M 		ITGR
$20.5M 		CNMD
$19.7M 		NUVA
$7.4M 		SRDX
$247,000 		LUNG
-$13.7M 		CVRX
-$22.2M 		OFIX
-$36.0M 		GKOS
-$40.8M
Quarterly Free Cash Flow $78.4 Million 3/16 MDT
$2.4B 		ABT
$627.0M 		ZBH
$78.4M 		SYK
$37.0M 		BIO
$29.0M 		CNMD
$27.1M 		SRDX
$6.1M 		BRKR
$400,000 		LUNG
-$0 		NUVA
-$495,000 		ITGR
-$5.8M 		CVRX
-$11.8M 		OFIX
-$29.4M 		GKOS
-$34.8M 		BSX
-$81.0M 		EW
-$138.8M
Trailing 4 Quarters Revenue $5.7 Billion 7/16 BIO
$2.7T		 ABT
$40.3B		 MDT
$32.4B		 SYK
$21.0B		 BSX
$14.7B		 EW
$6.1B		 ZBH
$5.7B		 BRKR
$3.0B		 ITGR
$1.9B		 CNMD
$1.3B		 NUVA
$1.2B		 OFIX
$760.0M		 GKOS
$326.4M		 SRDX
$143.0M		 LUNG
$53.7M		 CVRX
$42.1M
Trailing 4 Quarters Earnings $544.8 Million 6/16 ABT
$10.0B 		MDT
$8.6B 		SYK
$5.2B 		BSX
$3.9B 		ZBH
$1.9B 		EW
$1.6B 		BRKR
$721.7M 		BIO
$610.8M 		ITGR
$414.8M 		NUVA
$317.8M 		CNMD
$312.3M 		OFIX
$188.6M 		GKOS
$85.6M 		SRDX
$32.0M 		LUNG
$18.9M 		CVRX
$10.8M
Quarterly Earnings Growth -26% 13/16 CNMD
984% 		NUVA
925% 		BIO
457% 		SRDX
103% 		BSX
57% 		ITGR
57% 		OFIX
41% 		SYK
33% 		LUNG
13% 		EW
3% 		ABT
-7% 		GKOS
-18% 		ZBH
-26% 		BRKR
-33% 		MDT
-45% 		CVRX
-95%
Annual Earnings Growth 445% 1/16 ZBH
445% 		SRDX
228% 		BSX
141% 		SYK
47% 		ITGR
46% 		ABT
27% 		LUNG
24% 		BRKR
9% 		CNMD
1% 		EW
-8% 		GKOS
-9% 		CVRX
-21% 		MDT
-24% 		NUVA
-50% 		OFIX
-54% 		BIO
-25060%
Quarterly Revenue Growth 3% 12/16 CVRX
35% 		LUNG
30% 		SRDX
18% 		GKOS
16% 		BSX
14% 		SYK
10% 		ITGR
10% 		EW
9% 		OFIX
8% 		CNMD
6% 		BRKR
5% 		ZBH
3% 		ABT
2% 		NUVA
2% 		MDT
1% 		BIO
-10%
Annual Revenue Growth -22% 16/16 BIO
93047% 		CVRX
43% 		SRDX
40% 		OFIX
40% 		ITGR
29% 		CNMD
20% 		GKOS
14% 		BSX
12% 		EW
12% 		BRKR
7% 		NUVA
4% 		SYK
3% 		MDT
2% 		ABT
1% 		LUNG
-12% 		ZBH
-22%
Cash On Hand $393.0 Million 7/16 ABT
$6.3B 		SYK
$2.3B 		BSX
$2.3B 		MDT
$1.3B 		EW
$1.2B 		BIO
$433.3M 		ZBH
$393.0M 		BRKR
$340.1M 		NUVA
$80.7M 		CVRX
$80.1M 		LUNG
$70.2M 		GKOS
$42.5M 		ITGR
$42.2M 		CNMD
$33.9M 		SRDX
$33.0M 		OFIX
$29.5M
Short Term Debt $970.0 Million 5/16 SYK
$2.1B 		ABT
$2.0B 		MDT
$1.1B 		BSX
$1.1B 		ZBH
$970.0M 		NUVA
$360.8M 		BIO
$40.5M 		EW
$24.8M 		BRKR
$21.2M 		ITGR
$8.6M 		OFIX
$7.4M 		LUNG
$5.2M 		SRDX
$1.0M 		CNMD
$692,000 		CVRX
$239,000 		GKOS
-$0
Long Term Debt $4.8 Billion 5/16 MDT
$23.9B		 ABT
$12.6B		 SYK
$10.8B		 BSX
$9.9B		 ZBH
$4.8B		 BRKR
$1.4B		 BIO
$1.2B		 ITGR
$1.1B		 CNMD
$990.1M		 EW
$597.2M		 NUVA
$545.4M		 GKOS
$283.1M		 OFIX
$115.1M		 LUNG
$32.7M		 SRDX
$29.5M		 CVRX
$29.3M
PE 41.78 3/16 NUVA
73.28		 BSX
61.65		 ZBH
41.78		 ITGR
39.51		 SYK
37.11		 ABT
30.92		 MDT
27.37		 CNMD
26.56		 EW
25.45		 BRKR
24.20		 SRDX
14.74		 GKOS
-1.00		 BIO
-1.00		 OFIX
-1.00		 LUNG
-1.00		 CVRX
-1.00
PS 4.00 9/16 GKOS
18.15		 BSX
7.42		 SYK
5.95		 EW
5.86		 LUNG
5.60		 CVRX
4.93		 ABT
4.32		 SRDX
4.14		 ZBH
4.00		 BRKR
3.24		 MDT
3.11		 ITGR
2.01		 CNMD
1.73		 NUVA
1.70		 OFIX
0.82		 BIO
0.00
PB 1.81 14/16 GKOS
13.15		 BRKR
6.70		 SYK
6.51		 BSX
5.41		 EW
5.01		 SRDX
4.77		 ABT
4.46		 CVRX
3.13		 LUNG
2.72		 CNMD
2.56		 ITGR
2.54		 NUVA
2.34		 MDT
2.00		 ZBH
1.81		 OFIX
1.09		 BIO
0.99
PC 57.92 5/16 GKOS
139.45		 ITGR
91.94		 MDT
78.35		 CNMD
64.59		 ZBH
57.92		 SYK
53.54		 BSX
46.88		 EW
29.38		 BRKR
28.58		 ABT
27.70		 NUVA
25.83		 OFIX
21.03		 BIO
20.77		 SRDX
17.90		 LUNG
4.29		 CVRX
2.59
Liabilities to Equity 0.70 10/16 BRKR
2.16		 CNMD
1.70		 NUVA
1.34		 GKOS
1.07		 SYK
1.06		 ITGR
1.04		 ABT
0.86		 BSX
0.83		 MDT
0.79		 ZBH
0.70		 CVRX
0.60		 OFIX
0.59		 LUNG
0.49		 SRDX
0.47		 BIO
0.39		 EW
0.36
ROA 0.03 9/16 SRDX
22% 		EW
15% 		SYK
9% 		BRKR
9% 		ABT
8% 		BSX
5% 		MDT
4% 		CNMD
4% 		ZBH
3% 		ITGR
3% 		NUVA
1% 		OFIX
-14% 		GKOS
-15% 		LUNG
-27% 		CVRX
-49% 		BIO
-5052%
ROE 0.04 10/16 SRDX
32% 		BRKR
28% 		EW
20% 		SYK
18% 		ABT
15% 		CNMD
10% 		BSX
9% 		MDT
7% 		ITGR
6% 		ZBH
4% 		NUVA
3% 		OFIX
-22% 		GKOS
-31% 		LUNG
-41% 		CVRX
-78% 		BIO
-7038%
Current Ratio 2.42 7/16 EW
3.82		 BIO
3.54		 SRDX
3.11		 LUNG
3.04		 OFIX
2.70		 CVRX
2.66		 ZBH
2.42		 MDT
2.27		 BSX
2.22		 ABT
2.17		 ITGR
1.96		 SYK
1.95		 GKOS
1.93		 NUVA
1.75		 CNMD
1.59		 BRKR
1.47
Quick Ratio 0.04 14/16 NUVA
73.28		 BSX
61.65		 ZBH
41.78		 ITGR
39.51		 SYK
37.11		 ABT
30.92		 MDT
27.37		 CNMD
26.56		 EW
25.45		 BRKR
24.20		 SRDX
14.74		 GKOS
-1.00		 BIO
-1.00		 OFIX
-1.00		 LUNG
-1.00		 CVRX
-1.00
Long Term Debt to Equity 0.38 10/16 CNMD}
1.16		 BRKR}
0.96		 ITGR}
0.75		 GKOS}
0.63		 NUVA}
0.61		 SYK}
0.56		 BSX}
0.50		 MDT}
0.48		 CVRX}
0.44		 ZBH}
0.38		 ABT}
0.32		 LUNG}
0.30		 SRDX}
0.24		 OFIX}
0.20		 BIO}
0.13		 EW}
0.08
Debt to Equity 0.46 9/16 CNMD
1.16		 BRKR
1.03		 NUVA
1.02		 GKOS
0.85		 ITGR
0.81		 SYK
0.56		 BSX
0.55		 MDT
0.50		 ZBH
0.46		 CVRX
0.46		 ABT
0.38		 LUNG
0.34		 OFIX
0.28		 SRDX
0.27		 BIO
0.15		 EW
0.10
Burn Rate 1.49 10/16 BRKR
39.13		 SRDX
27.93		 SYK
14.67		 BSX
13.24		 LUNG
4.29		 CVRX
3.42		 MDT
2.23		 CNMD
1.69		 ITGR
1.55		 ZBH
1.49		 GKOS
0.81		 NUVA
0.77		 OFIX
0.69		 BIO
-1.33		 EW
-3.81		 ABT
-28.63
Cash to Cap 0.02 10/16 CVRX
0.39		 LUNG
0.23		 SRDX
0.06		 BIO
0.05		 OFIX
0.05		 ABT
0.04		 NUVA
0.04		 EW
0.03		 BRKR
0.03		 ZBH
0.02		 BSX
0.02		 SYK
0.02		 CNMD
0.02		 MDT
0.01		 GKOS
0.01		 ITGR
0.01
CCR 0.45 8/16 SRDX
24.87		 MDT
3.59		 CNMD
1.37		 GKOS
0.85		 OFIX
0.82		 CVRX
0.53		 ABT
0.51		 ZBH
0.45		 BIO
0.08		 SYK
0.05		 BRKR
0.01		 LUNG
0.00		 NUVA
-0.07		 BSX
-0.16		 ITGR
-0.28		 EW
-0.39
EV to EBITDA 49.86 11/16 SRDX}
214.81		 ABT}
125.78		 BSX}
117.73		 SYK}
107.78		 BIO}
99.88		 BRKR}
95.71		 CNMD}
89.79		 ITGR}
69.62		 EW}
67.34		 MDT}
50.49		 ZBH}
49.86		 NUVA}
47.54		 CVRX}
-7.15		 LUNG}
-18.98		 OFIX}
-56.17		 GKOS}
-361.13
EV to Revenue 4.94 6/16 GKOS
19.20		 BSX
8.01		 SYK
6.35		 EW
5.77		 LUNG
5.00		 ZBH
4.94		 ABT
4.52		 SRDX
4.14		 MDT
3.84		 CVRX
3.75		 BRKR
3.61		 ITGR
2.62		 CNMD
2.49		 NUVA
2.37		 OFIX
0.98		 BIO
0.00

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions